SCHEMBL991496

SCHEMBL991496

CCCCCCCCOCCc1cc[c]cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
CYP3A4 P08684 2/20 0.42
USP2 O75604 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SLCO1B3 Q9NPD5 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
ESR1 P03372 2/20 0.39
ADRA2A P08913 2/20 0.39
ADORA3 P0DMS8 2/20 0.39
TACR2 P21452 2/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305774 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL16892547 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL16055970 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL16892584 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL7305849 0.98 MEN1 (0.44) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL7297264 0.98 MEN1 (0.40) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL7296008 0.96 MEN1 (0.42) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL16892524 0.93 ALDH1A1 (0.45) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL16892528 0.93 ALDH1A1 (0.49) MEN1KMT2AALDH1A1LMNACYP3A4
SCHEMBL16892535 0.93 ALDH1A1 (0.49) MEN1KMT2AALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2894685-B1 BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR DAINIPPON INK & CHEMICALS (JP) 2018-10-31 EP disclosed
US-9490433-B2 Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor DIC CORPORATION (JP) 2016-11-08 US disclosed
US-9112081-B2 Sealing film for solar cell and solar cell obtained by use of the sealing film BRIDGESTONE CORPORATION (JP) 2015-08-18 US disclosed
US-20150228913-A1 BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR DIC CORPORATION (JP) 2015-08-13 US disclosed
EP-2894685-A1 BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR DIC Corporation (JP) 2015-07-15 EP disclosed
CN-104769735-A Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor CENTRE NAT RECH SCIENT 2015-07-08 CN disclosed
CN-101960616-B Sealing film for solar cell and solar cell using same BRIDGESTONE CORP 2013-12-18 CN disclosed
CN-101960616-A Sealing film for solar cell and solar cell using same BRIDGESTONE CORP 2011-01-26 CN disclosed
US-20110005592-A1 SEALING FILM FOR SOLAR CELL AND SOLAR CELL OBTAINED BY USE OF THE SEALING FILM BRIDGESTONE CORPORATION (JP) 2011-01-13 US disclosed
EP-2259331-A1 SEALING FILM FOR SOLAR CELLS AND SOLAR CELL USING THE SAME Bridgestone Corporation (JP) 2010-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150228913-A1 BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR TST, TPST2, TPR MEN1 3885/4885KMT2A 230/4885ALDH1A1 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.